Literature DB >> 8934020

Brain alterations in the classical form of congenital muscular dystrophy. Clinical and neuroimaging follow-up of 12 cases and correlation with the expression of merosin in muscle.

C P Trevisan1, F Martinello, E Ferruzza, M Fanin, M Chevallay, F M Tomé.   

Abstract

In the classical form of congenital muscular dystrophy (CMD), subclinical brain involvement is frequent. In order to establish the natural evolution of CNS alterations in this type of CMD, the cerebral functions of 12 cases were examined longitudinally for a mean period of 8 years. There were 7 boys and 5 girls, with a mean age of 5 years at first evaluation and 13 at the last one. Merosin expression in muscle fiber basement membrane, evaluated in 10 of them, was normal in 6 and deficient in 4. CNS conditions were followed up by repeated neuropsychiatric examinations, intelligence tests, EEG and brain CT scan and/or MRI. Eight of the 12 patients (including the 4 with merosin-deficiency) had normal intelligence, while 4 had mild to moderate mental retardation: in all the intellectual ability was unchanged during the follow-up study. CT scan detected minor brain alterations in 9 patients: 6 of these, the 4 with merosin deficiency and 2 others in whom merosin was not evaluated, presented leukoencephalopathy: on neuroimaging reappraisal it was unchanged in 3, improved in 2 and worse in 1 (a merosin-deficient case). Cerebellar alterations or mild ventricular dilatation were detected in 8 cases, including 3 merosin-non-deficient ones: these abnormalities were unchanged at the last study by CT and MRI, as were the normal neuroimaging findings observed in 3 other cases. Overall, during our study the brain alterations found in classical CMD showed a stationary or an improving course; progressive worsening was observed only in 1 of 4 merosin-deficient cases with leukoencephalopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8934020     DOI: 10.1007/BF00261655

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  13 in total

1.  Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. 22-24 April 1994, The Netherlands.

Authors:  V Dubowitz; M Fardeau
Journal:  Neuromuscul Disord       Date:  1995-05       Impact factor: 4.296

2.  Abnormal localization of laminin subunits in muscular dystrophies.

Authors:  Y K Hayashi; E Engvall; E Arikawa-Hirasawa; K Goto; R Koga; I Nonaka; H Sugita; K Arahata
Journal:  J Neurol Sci       Date:  1993-10       Impact factor: 3.181

3.  Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33.

Authors:  T Toda; M Segawa; Y Nomura; I Nonaka; K Masuda; T Ishihara; M Sakai; I Tomita; Y Origuchi; M ] Suzuki M [corrected to Sakai
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

4.  Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping.

Authors:  D Hillaire; A Leclerc; S Fauré; H Topaloglu; N Chiannilkulchaï; P Guicheney; L Grinas; P Legos; J Philpot; T Evangelista
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

5.  Involvement of the central nervous system in congenital muscular dystrophies.

Authors:  J Egger; B E Kendall; M Erdohazi; B D Lake; J Wilson; E M Brett
Journal:  Dev Med Child Neurol       Date:  1983-02       Impact factor: 5.449

6.  Muscle-eye-brain disease and Fukuyama type congenital muscular dystrophy are not allelic.

Authors:  S Ranta; H Pihko; P Santavuori; E Tahvanainen; A de la Chapelle
Journal:  Neuromuscul Disord       Date:  1995-05       Impact factor: 4.296

7.  Congenital muscular dystrophy with merosin deficiency.

Authors:  F M Tomé; T Evangelista; A Leclerc; Y Sunada; E Manole; B Estournet; A Barois; K P Campbell; M Fardeau
Journal:  C R Acad Sci III       Date:  1994-04

8.  Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy.

Authors:  M L Mostacciuolo; M Miorin; F Martinello; C Angelini; P Perini; C P Trevisan
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

9.  Congenital muscular dystrophy: brain alterations in an unselected series of Western patients.

Authors:  C P Trevisan; C Carollo; P Segalla; C Angelini; P Drigo; R Giordano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

10.  Divergence of central nervous system involvement in 2 Italian sisters with congenital muscular dystrophy: a clinical and neuroradiological follow-up.

Authors:  C P Trevisan; F Martinello; E Ferruzza; C Angelini
Journal:  Eur Neurol       Date:  1995       Impact factor: 1.710

View more
  4 in total

1.  Merosin-deficient congenital muscular dystrophy with cerebral white matter changes: a clue to its diagnosis beyond infancy.

Authors:  Sandeep Kumar; Shrikiran Aroor; Suneel Mundkur; Maneesh Kumar
Journal:  BMJ Case Rep       Date:  2014-03-06

Review 2.  The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review.

Authors:  K J Jones; G Morgan; H Johnston; V Tobias; R A Ouvrier; I Wilkinson; K N North
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

3.  Merosin-deficient congenital muscular dystrophy (CMD): a study of 25 Brazilian patients using MRI.

Authors:  Claudia C Leite; Leandro T Lucato; Maria G M Martin; Lucio G Ferreira; Maria B D Resende; Mary S Carvalho; Suely K N Marie; J Randy Jinkins; Umbertina C Reed
Journal:  Pediatr Radiol       Date:  2005-03-05

Review 4.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.